| ADVM Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the ADVM shares outstanding history going back to 7/31/2014:
Also see: ADVM Market Cap History ADVM YTD Return |
ADVM Shares Outstanding History — Adverum Biotechnologies Share Count Over Time
As of 11/7/2025 Adverum Biotechnologies has 22.08 million ADVM shares outstanding. Investors often track the ADVM shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows ADVM share count trends over time, with 46 historical shares outstanding datapoints presented, dating back to 7/31/2014.
| ADVM Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADVM Historical Shares Outstanding: +23.31% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADVM Stock Price Chart |
| About Adverum Biotechnologies Inc |
| Adverum Biotechnologies, Inc. is a clinical-stage gene therapy company. Co. discovers and develops gene therapy product candidates that provides durable efficacy by inducing sustained expression of a therapeutic protein. Its lead product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable levels of aflibercept associated with a sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with frequent anti-vascular endothelial growth factor (VEGF) IVT injections. We show 46 historical shares outstanding datapoints in our coverage of ADVM's shares outstanding history. Understanding the changing numbers of ADVM shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ADVM versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ADVM by allowing them to research ADVM shares outstanding history as well as any other stock in our coverage universe. |
| ADVM Current Stock Quote |
Quotes delayed 20 minutes  Free ADVM Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| ADVM Share Performance |
| Shares Outstanding Peers |
| Adverum Biotechnologies (ADVM) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
ADXS Shares Outstanding History ADYX Shares Outstanding History AEMD Shares Outstanding History AERI Shares Outstanding History AEZS Shares Outstanding History AFIB Shares Outstanding History AGEN Shares Outstanding History AGIO Shares Outstanding History AGL Shares Outstanding History AGLE Shares Outstanding History More Healthcare companies » |
ADVM Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
